Representing the Hub
Our Board of Directors at Life Sciences Hub Wales brings considerable knowledge and expertise to our organisation; with experience spanning the life sciences sector including the NHS, pharmaceutical industry and academia.
If you would like to find out more about the board and the support available from Life Sciences Hub Wales, email firstname.lastname@example.org.
Professor Sir Mansel Aylward CB MD DSc FFOM FRCP FLSW
Dr Rhodri Griffiths
Dr Melya Hughes Crameri PhD, BSc (Hons), EPA
Professor Tim Irish
Chris Martin B Pharm (Hons) FRPharmS
Dr Penny Owen
Chair of Life Sciences Hub Wales. He is also Chair of the Bevan Commission, an independent expert panel to oversee NHS reforms in Wales and to provide expert advice to the Cabinet Secretary for Health, Sport and Wellbeing. He is professor of Public Health Education at the Centre for Psychosocial and Disability Research at Cardiff University. He was recently appointed as professor of Prudent Health and Wellbeing at the School of Management, Swansea University.
He was the first Chair of Public Health Wales NHS Trust, responsible for the delivery of public health services at national, local and community levels in Wales. Earlier in his career he was Chief Medical Officer, Medical Director and Chief Scientist at the Department for Work and Pensions in London.
He was knighted in the Queen’s New Year’s Honours 2010 for services to health and healthcare. In 2016, he was elected to fellowship of the Learned Society of Wales.
Jarred came to PDR as commercial director in 2003 after a number of years working in the medical device sector. He saw it as a fantastic opportunity to develop the commercial elements of the organisation and create a truly world class design team. The blend of commercial practice and academic research at PDR is unique and continually pushes the team to learn and grow. Jarred says it is a privilege to lead such a wonderful team of people and to see the impact that we have on products and services that genuinely improve people’s lives.
A fluent Welsh speaker Rhodri has gained experience at senior management level in the commercial and voluntary sectors and worked extensively with the public sector over a number of years. He has a biochemistry based PhD and MBA specialising in strategy and change management. At one time director of the National Botanic Garden of Wales, he has extensive experience in life sciences having worked in R&D, public engagement and management. He has worked with numerous NHS organisations, private healthcare providers and health technology providers including major listed companies introducing new technology and innovative solutions into the NHS. He is currently Managing Director of Societas Management Ltd which delivers consultancy, advisory, project and management services for better public private partnerships.
Dr Melya Hughes Crameri is an entrepreneur and partner with Ventac Partners. With 20+ years’ experience in the life sciences industry in the USA and Europe, Melya has served several private companies in corporate strategy and business development. She served as VP Alliances & Intellectual Property of Evolva SA, a synthetic biology company, from Series A to its exit on the SIX Swiss Exchange, and was Founder, CEO and board member of Genetic Chemistry Inc. (Evolva’s US subsidiary), securing multi-million dollar discovery contracts and supporting $50M in venture funding. Previously, she served as Head of Licensing and Patents, Novartis Research Foundation (FMI). Melya is a European Patent Attorney and a U.S Patent Agent. She earned her BSc (Hons.) in Biochemistry from Cardiff University and her PhD in Biochemistry from the University of Basel, Switzerland. Melya represents the life science industry advising the Institute of Directors, Wales.
Tim Irish has worked in the life sciences industry for thirty years. His career has spanned global health technology companies across Europe and North America, including GSK, GE and Philips. Between 2007 and 2015 he served on ten Boards, five as Chair, where he successfully executed two trade sales, and raised significant equity financing, including an IPO. Tim’s current governance portfolio covers Life Sciences, Healthcare and Education, both public and private, including Board roles as Senior Independent Director/NED at the National Institute for Health and Care Excellence, three Digital/MedTech Board roles, and Professor of Practice at King’s College London’s School of Management and Business.
Mr. Rupert Jones has more than 25 years’ experience in life sciences since graduating from University of Wales Institute of Science and Technology and is currently Managing Director of the medical businesses of Renishaw plc. Prior to his current position, Rupert was General Manager at Renishaw Diagnostics Ltd and before that, he held senior positions at Renishaw, GE Healthcare and Amersham Biosciences gaining industry experience in product management, operations, quality, marketing and business development. Rupert is a first language Welsh speaker and cares passionately about Wales’ international success in the life sciences sector.
Chris is a Pharmacist by profession and has owned and built two successful independent community pharmacy businesses in the West Country and in Pembrokeshire. He is currently Deputy Chairman of the Bevan Commission with an interest in Innovation and a Non-Executive Director of the Health and Social Services Audit and Risk Committee in Welsh Government.
He was a member of the Life Sciences Hub Task and Finish Group and has an extensive experience in the public sector having been Chairman of four separate Health Organisations in West Wales over the past 18 years. He is Managing Director of his own property development company, Chairman of the Port of Milford Haven and a Non-Executive Advisor on the Board of Alliance Healthcare Distribution UK Ltd. He has several voluntary and charitable roles including Governor of Pembrokeshire College and Member of the Wales Advisory Board for Marie Curie.
Cath O’Brien is currently the Director of the Welsh Blood Service, Velindre NHS Trust where she has a successful track record in delivering major change programmes. Cath is currently supporting the Welsh Government in leading the programme team exploring the potential of Cell and Gene Therapy developments to both provide improved patient care and derive economic benefit. A pharmacist by profession, she spent her early career as a community pharmacist working in Cardiff and the south Wales valleys before moving to senior strategic management roles in commercial pharmacy companies. In 2002 she was appointed as the Director for Wales for the Royal Pharmaceutical Society and subsequently undertook a range of UK wide roles on policy development and engaging with commercial pharmacy companies and academic institutions. Moving to Cardiff University in 2007 she headed the Wales centre for pharmacy professional education, providing post graduate education and training for the pharmacy team. She has a particular interest in workforce development.
Penny Owen has more than 20 years experience in the life sciences industry, working closely with Pharma/Biotech companies on drug discovery technologies. A senior business leader in the life sciences industry with demonstrated track record in the commercialisation of technology developments. Experienced cross-functional leader, managing global teams with roles in R&D, Marketing and Operations within a major multinational company and of supporting start-ups & SMEs.
Penny has experience of commercialising a variety of products, from molecular biology reagents to large imaging instruments. Penny was a member of the Welsh Government Life Sciences Sector Panel (2011-2014).